-The Economic Times Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, talks to ET about the five-year long investigation and the future of generic drug companies in the US. Edited Excerpts: * You think you...
More »SEARCH RESULT
Total Matching Records found : 6301
Behind the success of every Jasauti farmer is a lady’s finger-Mohammed Iqbal
-The Hindu Jaipur: The nondescript Jasauti village in Pahari tehsil of Bharatpur district, situated at the Rajasthan-Haryana border, has emerged as the "Bhindi Gaon" (village of lady's fingers), sending over a dozen vehicles with the popular vegetable everyday for six months in a year to Gurgaon and Delhi. Eighty per cent of agriculturists in the village are engaged in the farming of lady's fingers. The transformation in both the social and...
More »Aam aadmi’s advice to Aam Aadmi Party: Go regional, then national -Paramita Ghosh
-The Hindustan Times Although crusader-turned-politician Arvind Kejriwal seems optimistic about his Aam Aadmi Party's (AAP) performance in the upcoming Delhi assembly polls, many voters apparently think otherwise. Many of the voters in Delhi hail Kejriwal's decision of launching the party, but they are not sure whether they would exercise their franchise in favour of the newly-launched 'people's party'. According to them, the party lacks local presence, has a one-point agenda and indicates no...
More »The rise and fall of Mahendra Karma – the Bastar Tiger -Suvojit Bagchi
-The Hindu Raipur: Launching the Congress party's ‘Parivartan Yatra' (March for Change) on Thursday in Bastar, a senior Central Minister, Jairam Ramesh, compared Mahendra Karma, the tribal leader, with a "slow tiger." "Mahendra Karma was called the ‘Bastar Tiger.' But the tiger has slowed down over the years," said the Minister in the presence of Mr. Karma and about two thousand Gond tribals. Sitting on the dais, Mr. Karma's reactions changed...
More »USFDA scrutiny: Will pharma majors like Ranbaxy, Wockhardt be affected in long-term? -G Seetharaman
-The Economic Times Japanese companies do not mind erring on the side of caution. They are known to think longer and harder than their counterparts in other countries about big decisions, especially when it comes to entering a new market or acquiring a foreign company. But Japan's third biggest drugmaker Daiichi Sankyo would now wish it had spent more time doing due diligence on Ranbaxy Labs, in which it bought a...
More »
